XML 26 R12.htm IDEA: XBRL DOCUMENT
v3.4.0.3

ACQUISITIONS AND OTHER ARRANGEMENTS | 3 Months Ended
--- | ---
Mar. 31, 2016
ACQUISITIONS AND OTHER ARRANGEMENTS | 5. ACQUISITIONS AND OTHER ARRANGEMENTS In the first quarter of 2016, Baxter paid approximately $23 million to acquire the rights to Vancomycin injection in 0.9% Sodium Chloride (Normal Saline) in 500mg, 750mg, and 1 gram presentations from Celerity Pharmaceuticals, LLC (Celerity). Baxter capitalized the purchase price as an intangible asset and is amortizing the asset over the estimated economic life of 12 years. Refer to Note 5 within the 2015 Annual Report for additional information regarding the company’s agreement with Celerity.

X
- Definition Acquisitions and other arrangements disclosure [Text Block] + References No definition available. + Details
Name: | bax_AcquisitionsAndOtherArrangementsDisclosureTextBlock
Namespace Prefix: | bax_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration